July 9, 2026 — A new artificial intelligence (AI) clinical tool developed by researchers at the University of Maryland Institute for Health Computing (UM-IHC) and the University of Maryland School of ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
Aug. 13, 2026 — Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the ...
Aug. 4, 2026 — Abbott has completed enrollment in its TECTONIC coronary artery disease (CAD) Intravascular Lithotripsy ...
July 23, 2026 — The results of 59 ground-breaking trials will be unveiled for the first time at ESC Congress 2026, the ...
July 21, 2026 — Women who experience pregnancy complications face an increased risk of developing peripheral artery ...
July 20, 2026 — Young women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovarian ...
July 9, 2026 — A new artificial intelligence (AI) clinical tool developed by researchers at the University of Maryland ...
June 25, 2026 — Johnson & Johnson has announced the initiation of its Skyward investigational device exemption (IDE) ...
June 23, 2026 — The European Society of Cardiology (ESC) Congress 2026 will take place in Munich Aug. 28–31, 2026. ESC ...
June 17, 2026 — VahatiCor, Inc., a medtech company developing interventional therapies for coronary microvascular ...
June 13, 2026 — New research shows that infrainguinal endovascular interventions for peripheral artery disease (PAD) ...
June 9 2026 — With the project “Triaging artificial intelligence (AI) Tool For Pulmonary Health Using Spectral X-ray ...
May 20, 2026 — Medtronic has released the three-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) ...
May 10, 2026 — WhiteSwell has announced primary results from the DELTA-HF feasibility clinical trial evaluating the eLym ...
May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...
May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
August 14, 2026